Comparing cotinine and NNAL verification of self-reported smoking status among lung cancer screening eligible population from the 2007–2014 National Health and Nutrition Examination Survey (NHANES)

References

• Agaku, I.T., Vardavas, C.I., and Connolly, G., 2013. Proposed cutoff for identifying adult smokeless tobacco users with urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanonol: an aggregated analysis of NHANES 2007-2010 data. Nicotine & tobacco research: official journal of the society for research on nicotine and tobacco, 15 (11), 1956–1961.
   PubMed Web of Science ®Google Scholar
• Agaku, I.T., Vardavas, C.I., and Connolly, G.N., 2014. Cigarette rod length and its impact on serum cotinine and urinary total NNAL levels, NHANES 2007-2010. Nicotine & tobacco research: official journal of the society for research on nicotine and tobacco, 16 (1), 100–107.
   PubMed Web of Science ®Google Scholar
• Ali, M., et al., 2017. Tobacco exposure as determined by serum cotinine and subclinical myocardial injury in individuals free from cardiovascular disease. American Journal of cardiology, 120, 1114–1117.
   PubMed Web of Science ®Google Scholar
• Barr, D.B., et al., 2005. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environmental health perspectives, 113 (2), 192–200.
   PubMed Web of Science ®Google Scholar
• Belani, C.P., et al., 2007. Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research. Lung cancer (Amsterdam, Netherlands), 55 (1), 15–23.
   PubMed Web of Science ®Google Scholar
• Benowitz, N.L., et al., 2003. Nicotine metabolite ratio as a predictor of cigarette consumption. Nicotine & tobacco research: official journal of the society for research on nicotine and tobacco, 5 (5), 621–624.
   PubMed Web of Science ®Google Scholar
• Benowitz, N.L., et al., 2006. Female sex and oral contraceptive use accelerate nicotine metabolism. Clinical pharmacology & therapeutics, 79 (5), 480–488.,
   PubMed Web of Science ®Google Scholar
• Benowitz, N.L., et al., 2009. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. American journal of epidemiology, 169 (2), 236–248.
   PubMed Web of Science ®Google Scholar
• Benowitz, N.L., et al., 2019. Biochemical verification of tobacco use and abstinence: 2019 update. Nicotine & tobacco research, 22 (7), 1086–1097
   Web of Science ®Google Scholar
• Caraballo, R.S., et al., 2011. Comparison of serum cotinine concentration within and across smokers of menthol and nonmenthol cigarette brands among non-Hispanic black and non-Hispanic white U.S. adult smokers, 2001-2006. Cancer epidemiology, biomarkers & prevention : a publication of the American association for cancer research, cosponsored by the American society of preventive oncology, 20 (7), 1329–1340.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention, 2017a. Cotinine Factsheet [Online]. Available from: https://www.cdc.gov/biomonitoring/Cotinine_FactSheet.html [Accessed 1 March 2020].
   Google Scholar
• Centers for Disease Control and Prevention, 2017b. NNAL (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) Factsheet [Online]. Available from: https://www.cdc.gov/biomonitoring/NNAL_FactSheet.html [Accessed 1 March 2020].
   Google Scholar
• Centers for Disease Control and Prevention, 2017c. About the National Health and Nutrition Examination Survey [Online]. Available from: https://www.cdc.gov/nchs/nhanes/about_nhanes.htm [Accessed 1 March 2020].
   Google Scholar
• Connor Gorber, S., et al., 2009. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine & tobacco research: official journal of the society for research on nicotine and tobacco, 11 (1), 12–24.
   PubMed Web of Science ®Google Scholar
• Cox, L.S., et al., 2003. Change in smoking status after spiral chest computed tomography scan screening. Cancer, 98 (11), 2495–2501.
   PubMed Web of Science ®Google Scholar
• Goniewicz, M.L., et al., 2009. Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Cancer epidemiology, biomarkers & prevention: a publication of the American association for cancer research, cosponsored by the American society of preventive oncology, 18 (12), 3421–3425.
   PubMed Web of Science ®Google Scholar
• Goniewicz, M.L., et al., 2011. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking. Nicotine & tobacco research, 13 (3), 202–208.
   PubMed Web of Science ®Google Scholar
• Hecht, S.S., 1998. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chemical research in toxicology, 11 (6), 559–603.
   PubMed Web of Science ®Google Scholar
• Hecht, S.S., 2002. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis, 23 (6), 907–922.
   PubMed Web of Science ®Google Scholar
• Hecht, S.S., et al., 1999. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer research, 59 (3), 590–596.
   PubMed Web of Science ®Google Scholar
• Hecht, S.S., Stepanov, I., and Carmella, S.G., 2016. Exposure and metabolic activation biomarkers of carcinogenic tobacco-specific nitrosamines. Accounts of chemical research, 49 (1), 106–114.
   PubMed Web of Science ®Google Scholar
• Henschke, C.I., Yip, R., and Miettinen, O.S., 2006. Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. Jama, 296, 180–184.
   PubMed Web of Science ®Google Scholar
• Hoffman, R.M. and Sanchez, R., 2017. Lung Cancer Screening. The medical clinics of North America, 101 (4), 769–785.
   PubMed Web of Science ®Google Scholar
• Hukkanen, J., Jacob, P., 3rd, and Benowitz, N.L., 2005. Metabolism and disposition kinetics of nicotine. Pharmacological reviews, 57 (1), 79–115.
   PubMed Web of Science ®Google Scholar
• Jain, R.B., 2016. Distributions of serum cotinine and urinary NNAL among daily cigarette smokers and inter-correlations. Journal of environment and health science, 2, 1–13.
   Google Scholar
• Jain, R.B., 2017. Analysis of self-reported versus biomarker based smoking prevalence: methodology to compute corrected smoking prevalence rates. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals, 22 (5), 476–487.
   PubMed Web of Science ®Google Scholar
• Kalkbrenner, A.E., et al., 2010. Determinants of serum cotinine and hair cotinine as biomarkers of childhood secondhand smoke exposure. Journal of exposure science & environmental epidemiology, 20 (7), 615–624.
   PubMed Web of Science ®Google Scholar
• Liu, B., et al., 2020. Serum cotinine verification of self-reported smoking status among adults eligible for lung cancer screening in the 1999-2018 National Health and Nutrition Examination Survey. Lung cancer (Amsterdam, Netherlands), 144, 49–56.
   PubMed Web of Science ®Google Scholar
• Malhotra, J., et al., 2016. Risk factors for lung cancer worldwide. The European respiratory journal, 48 (3), 889–902.
   PubMed Web of Science ®Google Scholar
• O'Brien, K.M., et al., 2016. Environmental Chemicals in urine and blood: improving methods for creatinine and lipid adjustment. Environmental health perspectives, 124, 220–227.
   PubMed Web of Science ®Google Scholar
• O'Brien, K.M., Upson, K., and Buckley, J.P., 2017. Lipid and creatinine adjustment to evaluate health effects of environmental exposures. Current environmental health reports, 4, 44–50.
   PubMedGoogle Scholar
• Park, S.L., et al., 2015. Variation in levels of the lung carcinogen NNAL and its glucuronides in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American association for cancer research, cosponsored by the American society of preventive oncology, 24 (3), 561–569.
   PubMed Web of Science ®Google Scholar
• Pérez-Stable, E.J., et al., 1998. Nicotine metabolism and intake in black and white smokers. Jama, 280 (2), 152–156.
   PubMed Web of Science ®Google Scholar
• Pyenson, B.S., and Tomicki, S.M., 2018. Lung cancer screening: a cost-effective public health imperative. American journal of public health, 108 (10), 1292–1293.
   PubMed Web of Science ®Google Scholar
• Raja, M., et al., 2016. Diagnostic methods for detection of cotinine level in tobacco users: a review. Journal of clinical and diagnostic research: jcdr, 10 (3), ZE04–ZE06.
   PubMed Web of Science ®Google Scholar
• Ross, K.C., et al., 2016. Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking. Pharmacology, biochemistry, and behavior, 148, 1–7.
   PubMed Web of Science ®Google Scholar
• Stapelfeld, C., Neumann, K.T., and Maser, E., 2017. Different inhibitory potential of sex hormones on NNK detoxification in vitro: a possible explanation for gender-specific lung cancer risk. Cancer Letters, 405, 120–126.
   PubMed Web of Science ®Google Scholar
• Studts, J.L., et al., 2006. Validity of self-reported smoking status among participants in a lung cancer screening trial. Cancer epidemiology biomarkers & prevention, 15, 1825–1828.
   PubMed Web of Science ®Google Scholar
• Subcommittee, S., 2002. Biochemical verification of tobacco use and cessation. Nicotine & tobacco research, 4, 149–159.
   PubMedGoogle Scholar
• United States Preventive Services Task Force, 2020. Draft Recommendation Statement for lung cancer screening [Online]. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/lung-cancer-screening-2020 [Accessed 20 July 2020].
   Google Scholar
• van der Aalst, C.M. and DE Koning, H.J., 2016. Biochemical verification of the self-reported smoking status of screened male smokers of the Dutch-Belgian randomized controlled lung cancer screening trial. Lung cancer (Amsterdam, Netherlands), 94, 96–101.
   PubMed Web of Science ®Google Scholar
• Wei, B., et al., 2016. Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011-2012. Journal of exposure science and environmental epidemiology, 26, 249–256.
   PubMed Web of Science ®Google Scholar
• Xia, Y., et al., 2011. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008. Biomarkers, 16, 112–119.
   PubMed Web of Science ®Google Scholar
• Yuan, J.M., et al., 2011. Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers. Cancer research, 71 (21), 6749–6757.
   PubMed Web of Science ®Google Scholar
• Yuan, J.M., et al., 2014. Urinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer. Cancer research, 74 (2), 401–411.
   PubMed Web of Science ®Google Scholar
• Zipf, G., et al. 2013. National health and nutrition examination survey: plan and operations, 1999-2010. Vital and health statistics, 1, 1–37.
   Google Scholar